Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...
MedPage Today on MSN
'They've Just Gotten It Wrong': Vaccine Shift Raises Fears of Hepatitis A, B Surges
The change follows a controversial recommendation from the CDC's Advisory Committee on Immunization Practices (ACIP) to no ...
GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.
An advisory panel to the CDC voted to stop recommending hepatitis B shots at birth for most newborns. Why doctor says that's ...
GSK will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory ...
Hepatitis B is not a particularly common condition in the United States. Data from 2021 estimates that between 880,000 and 1.89 million individuals are living with chronic hepatitis B in the U.S. This ...
Zacks Investment Research on MSN
GSK's chronic hepatitis B drug meets goals in two late-stage studies
GSK plc GSK announced positive results from two phase III studies, B-Well 1 and B-Well 2, which evaluated its investigational ...
Hepatitis B and herpes simplex virus are both sexually transmitted infections (STIs). However, they are not the same and develop due to different viruses. STIs spread from one person to another ...
Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.
Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...
Most Americans have never thought much about hepatitis B, and that’s precisely because the vaccine works so well.
The Tuskegee syphilis study stands as one of the greatest moral failures in American medical history, a reminder of what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results